View Article

Abstract

Oral drug delivery: This system enables dosage forms to remain in the stomach for a longer duration, allowing for a slow release of the drug. This approach addresses several drawbacks of traditional oral delivery methods, particularly the issue of poor bioavailability. These dosage forms are designed to release drugs in the upper part of the gastrointestinal tract, especially in the stomach, in a controlled manner, which can provide sustained release without significantly compromising overall bioavailability. A polymer is a large molecular compound characterized by long repeating chains and can be either natural or synthetic, each with unique advantages. Polymers are valued for their ability to control drug release, their favourable flow properties, and their potential to enhance drug dissolution, ultimately improving bioavailability and stability during bodily processing. Often, a combination of natural and synthetic polymers is utilized to take advantage of their strengths and mitigate the weaknesses of existing polymers. This review discusses various polymers and other substances used in the formulation of gastro retentive drug delivery systems, including hydrodynamically balanced systems, raft systems, muco-adhesive systems, floating systems, high-density systems, and magnetic systems. Additionally, it presents an overview of various gastro retentive dosage forms along with the different drugs and polymers that have been employed in these formulations.

Keywords

Gastro Retentive Drug Delivery System, Natural Polymers, Synthetic Polymers, Floating system.

Introduction

Definition: A dose form that can remain in the stomach for a long period of time is known as a gastro retentive drug delivery mechanism [1].

Targeting site-specific medication release in the upper gastrointestinal tract for both local and systemic effects, it is a strategy for prolonging the stomach residence duration [2]. There are many therapeutic advantages of GRDDS that are not as great with oral standard systems. They show local drug activity, improve bioavailability and patient compliance, and lessen fluctuations in plasma drug concentration levels [3]. By prolonging the stomach residence time, astro-retentive drug delivery aims to target site-specific medication release in the upper gastrointestinal tract for both local and systemic effects. Compared to oral standard systems, GRDDS delivers more therapeutic benefits. They improve bioavailability and patient compliance, reduce fluctuations in plasma drug concentration levels, and demonstrate local drug activity [4].  Creating controlled release gastro-retentive forms can improve the solubility of drugs in high pH conditions and extend their gastrointestinal residence time for several hours. This would also help reduce drug waste. GRDDS can improve the regulated administration of drugs with a narrow absorption window by releasing them continuously [5].

FIGURE NO:1

INTRODUCTION OF POLYMER:

The term "polymer" originates from the Greek roots "Poly" signifying many and "meros" signifying parts. Polymer chains possess extremely high molecular weights because of the repeating units (monomers) they consist of. A category of macromolecules is presumed to consist of polymers. To create a polymer, a small molecule called a monomer combines with other molecules of the same or different types. Dimer, trimer, tetramer, or pentamer describes the compound formed when two, three, four, or five monomers are connected together Here are two components of drug release. The first component is polymer studies, while the second [6].

FIGURE NO:2

NATURAL POLYMERS:

In the pharmaceutical industry, polymers are utilized as solubilizers, stabilizers, mechanical supports, flow control agents for liquids, suspensions, and emulsions, tablet binder, film coating agents to mask drug taste, and protective and stable In the pharmaceutical industry, polymers are employed as mechanical supports, solvents, stabilizers, tablet binders, flow control agents for liquids, suspensions, and emulsions, film coating agents to cover the taste of medications, and stabilizing and protective compounds [7].Pharmaceutical polymers are frequently used to increase stability, improve bioavailability, and provide controlled release (such as prolonged, pulsed, and targeted). The pace at which a drug is released from a matrix product, which contains a sustained release characteristic agent, depends on the initial drug concentration and polymer chain relaxation [8]. Depending on the technological methods that have historically underpinned the FDF classification, targeted medication delivery in this instance takes the shape of a buoyant feature that can be attained in a number of ways. Currently, they can be divided into two primary directions: creating systems with a low starting density by adding air or explosives with a low bulk density, and creating systems whose density drops after ingestion as a result of gas production or swelling [9].

FIGURE NO3: Classification of technological approaches to achieve flotation, the purpose of polymers in these approaches, and the most common dosage forms.

SYNTHETIC POLYMER:

Medications frequently contain synthetic polymers. Synthetic polymers are frequently employed as film coating agents and binders. Large macromolecules with many functional groups are called polymers. Synthetic polymers can be fully synthetic or semi-synthetics, which are altered forms of natural polymers [10].

TABLE :1 Advantages and Disadvantages of Natural and Synthetic polymers[11].

Natural polymers

 

Synthetic polymers

Less toxic

• Biodegradable

• Biocompatibility

• Easily available

Advantages

• Biocompatibility

High degree of variability in natural materials derived from animal sources

• Structurally more complex

• Extraction process very complicated and high cost

Disadvantages

• Toxic

• Non degradable

• Synthetic process is very complicated and high cost

NATURAL POLYMERS:

GUAR GUM :

Cyamopsis tetragonolobus seeds are the source of this plant, which is a member of the Leguminosae family. A number of aliases are used to describe guar gum, including Cluster bean, Guaran, Calcutta lucerne, Cyamopsis, and Guarini. This powder has a whitish-yellow appearance and has no flavor or smell. While guar gum dissolves in water, it does not dissolve in organic solvents. It is used as a binder and dissolving agent in pharmaceutical tablets and can increase viscosity [12]. In the presence of a transparent water suspension, it grows quickly. Guar gum's constituents can be divided into two groups: water-soluble and non-water-soluble. Guaran, a hydrocolloid polysaccharide with a high molecular weight, accounts for around 85% of the soluble fraction. The hydrolysis of guaran results in the formation of 65% galactose and 35% mannose, which are connected by glycosidic linkages [13].

XANTHAN GUM:

It is a well-known biopolymer made of glucose, mannose, and glucuronic acid that is edible, natural, and biosynthetic. It has several uses, including thickening, suspending, emulsifying, gelling, stabilizing, and raising viscosity. Compared to HPMC, xanthan gum has zero-order drug release kinetics, which means that with greater electrolyte concentrations (potassium chloride or sodium chloride), drug release occurs more quickly. When it comes to controlled release formulations, particularly when included into tablets, xanthan gum is a fitting candidate. Because of its natural origin, biocompatibility, safety, and affordability of production, it is utilized as a pharmaceutical excipient [14].

CHITOSAN:

Chitosan is a linear amino polysaccharide that is produced when glucosamine and Acetylglucosamine copolymerize. Chitosan is a naturally occurring polymer that is produced when chitin undergoes deacetylation. It has beneficial biological properties such as biodegradability, biocompatibility, and non-toxicity. This polymer is appropriate for site specific delivery applications since it has antibacterial and bio adhesive qualities. Chitosan has a pKa value between 6.2 and 7, making it a polycationic weak base with a high molecular weight. It experiences buoyancy in neutral or acidic pH conditions (around 1.2), which makes controlled release methods easier. A chitosan film's thickness can slow down the release process by decreasing the pace at which chemicals are released [15].

CARRAGEENAN:

The marine red algae Chondrus crispus or Gigartina stellata, which belong to the Rhodophyceae class, are the source of carrageenan, which are high molecular weight sulphated polysaccharides. There are three primary types of carrageenan from a functional perspective: lambda, kappa, and iota. Specific carrageenan types differ structurally in relation to their water absorption and gel forming characteristics. For instance, iota (~ -carrageenan) and kappa (` carrageenan) create hydrogels with varying rigidities when in contact with water, whereas lambda type ({ -carrageenan) forms viscous solutions [16]. The two primary natural gelling polysaccharides that are isolated from plants or seaweeds (apart from starch) and utilized as high-value food ingredients are carrageenan and pectin; in 1997, their projected global sales were US$263 million. the three commercially used carbohydrate polymers from marine organisms are: (1) alginates, which are polymers from brown seaweeds that contain mannuronic and guluronic acids; (2) agar, which is a polymer from red seaweeds that contains o-galactose and anhydro-L-galactose; and (3) carrageenan [17].

SYNTHETIC POLYMER:

HYDROXY METHOXY PROPYL CELLOUSE:

Methoxy and hydroxy propyl, which have molecular weights ranging from 10,000 to 1,500,000 Dalton, are present in HPMC.  HPMC has the ability to create colloids and dissolve in water.  As a bio-adhesive polymer, HPMC can thicken preparations, improve coating activity, regulate media release, and function as an emulsion agent.  HPMC is frequently utilized in topical, ophthalmic, nasal, and oral therapies.  HPMC polymers are used as bonding ingredients in tablets, coating solutions, and controlled and delayed release [18]. To design new controlled drug delivery systems based on HPMC that are meant to provide specific, pre-determined release profiles, it is highly desirable to (i) comprehend the precise mass transport mechanisms involved in drug release and (ii) be able to quantitatively predict the resulting drug release kinetics. One practical benefit of having an adequate mathematical model is the ability to simulate the effects of design parameters on release profiles of HPMC-based drug delivery systems [5]. The ideal controlled drug delivery system would have the required geometry (size and shape) and composition (drug type and quantity, polymer, and additives) predicted theoretically in order to generate a certain drug release profile [19].

EUDRAGIT:

Eudragit is amorphous in nature. It comes from acrylic acid and polymization of mainly used for coating materials and taste-masking substances in oral methacrylic acids dosage forms via spray atomization methods. Its glass transition temperature spans from ninety to one hundred fifty degrees Celsius. This substance is unbiodegradable, non-absorbent and non-toxic. This polymer comes in two grades, L and S. L grade dissolves at pH 6 and finds usage for applied in colon-targeted systems; S grade dissolves at pH 7. Sustained release uses the RS and RL grades, which have a quaternary amino group.At pH 5, Eudragit E prevents medication release in saliva by not dissolving. Find Eudragit in different forms including powders, granules, organic solutions, and dispersions. Based on theWe have gone over their solubility, traits, and uses in grade. Ranitidine HCL was the active ingredient in developed floating microspheres made with twopolymers; HPMC and Eudragit grade E-100 in varying proportions. This mix produced long release inside the digestive tract, which improved absorption and increasedEudragit RL100 had quicker floating characteristics than Eudragit Refresher 100 [20].

Table 2: Various grade of Eudragit

Immediate Release

Colon Targeting

Delayed Release

E 100

FS 100

L 100

E P0

S 100

L 100-55

E 12,5

-

L 12,5

POLY VINYL PYRROLIDINE:

Polyvinylpyrrolidone (PVP), often known as polyvidone or povidone, is a biodegradable and water-soluble polymer derived from N-vinylpyrrolidone. PVP, a hydrophilic polymer, is highly soluble in various solvents, has strong binding characteristics, and may stabilize suspensions and emulsions. The FDA has recognized this biocompatible and nontoxic polymer as safe. As a result, PVP finds widespread application in the pharmaceutical and biomedical industries as well as in the food sector, medicine, and cosmetics. PVP has special physical and chemical properties, including chemical inertness, colorlessness, temperature resistance, and pH stability.Different molecular weights of six PVP are differentiated by different K-values, e.g. K12.K17 (7900–10,800 Daltons), K25 (23,000–32,000 Daltons), K30K90 (900,000–1,300,000 Daltons) and K35 (35,000–51,000 Daltons). PVP is finding uses.in the biomedical and pharmaceutical industries for the creation of various drug deliveryoral, topical, transdermal, and ocular approaches among systems. Moreover, PVP is otheruseful in gene delivery or can be coupled with metal particles for application in regenerativetargeted delivery and medicine. PVP's versatility makes it a very flexible plastic.Proposed for drug delivery systems are morphologies of PVP as the polymeric carrier.PVP helps poorly soluble medications' bioavailability by enabling regulated drug release.guards operating chemicals against pH, temperature, and oxygen among other environmental elements.and assists to cover bad scents and tastes. Many active chemicals over severalPVP microparticles and nanoparticles provide merged categories. Using a variety of processes, from conventional approaches like spray, these PVP-based particles have been createddrying to more sophisticated methods using supercritical fluids [21].

TABLE 3: VARIOUS POLYMERS USED IN GRDDS

Approaches

Description

Polymers used

Evaluation tests

References

Hydro dynamic balanced system (HBS)

In these system Hydrocolloids and medications are combined to create a formulation that floats on the stomach contents. These come in dose forms that are one unit in size. HBS system comprise one more hydrophilic gel-forming polymers.

Polycarbophil,

Alginic acid,

Sodium

carboxymethyl

cellulose,

HPMC,

Polyacrylate,

Hydroxy ethyl

cellulose (HEC),

Carrageenan’s

Hydroxypropyl

cellulose (HPC),

Polystyrene, or

Agar etc

Floating lag

time,

Total floating time,

Invitro drug release studies,

Swelling Index,

Density

measurement,

Stability studies,

Hardness,

Content uniformity

22

Raft systems integrating alginate gels

The dose form can float over stomach fluid because these contain a carbonate component that reacts with gastric acid to

produce bubbles in the gel.

Sodium alginate,

Sodium

bicarbonate,

Acid neutralizer.

Viscosity and

Rheology,

Floating lagtime

and Duration,

Gelstrength/Raft

strength,

Invitro Drug

Release Study

23,24, 25

 

Bio adhesive system

Bio adhesive polymer included in these devices can adhere to the GIT's epithelial layers. Electrostatic bonding and the stomach interface's edge are how bio adhesive systems function.

Sucralfate,

HPMC,

Cholestyramin

Dextrin,

Sodium

Alginate,

Tragacanth

Gliadin, Sodium ,

CMC ,Poly

acrylic acid,

Chitosan,

polylactic acids,

Lectin etc.

Mucoadhesive

strength,

Cohesion time

Swelling index,

Surface pH,

Drug content

uniformity,

Invitro drug

release,

Stability studies,

FTIR/DSC studies.

26

High density system

Pallets coated in these systems have a density of 1.004gm/cm3

which is higher than the stomach's contents. The high-density pellet used to prepare these kinds of pellets is based on the idea that thick pellets will remain in the stomach longer.

Zinc oxide,

Barium

sulphate,

Iron powder,

Titanium

dioxide

Apparent

Density

Measurement,

Invitro Buoyancy test,

Invitro drug release studies,

Matrix Integrity,

Hardness test,

Surface

morphology,

Swellingstudies,

Drug Content

uniformity

27,28, 29.

Swelling type system

Ingredients with swelling

properties are found in swelling type systems. and they enlarge so much that they are unable to flow out through the pylorus from the stomach. They can also be referred to as the "Plug type system," which keeps them in the pyloric sphincters for longer

Biodegradable

polymers are

used,

Swelling agents

(risperidone,

sodium starch

glycolate)

Gravimetric

method,

Dimensional

change

measurement,

Water uptake,

Visual

observation

and photographic

documentation

30,31, 32

Magnetic system

These systems use external stimuli as a magnetic field to deliver drugs precisely;

compounds with magnetic

activity are added to these

systems to achieve the desired drug delivery.

 

 

 

-

Magnetic field calibration test,

Magnetic Retention test,

Electromagnetic interference test

Ect.

33,34

 

Hollow Micro spheres

Hollow microsphere drug

delivery systems use

formulations with the

captured air in them that

are sustained or prolonged

released. Microspheres or

hollow microspheres offer

significant advantages for

achieving gastroprotective

medication delivery; these

hollow microspheres also

possess the ability to float

over the stomach contents

to have a therapeutic

effect.

Poly Vinyl

Alcohol

(PVA),

Poly D,

L-lactic

glycolic acid.

Particle size and

shape Analysis,

Surface

morphology,

Floating test,

Density

measurement,

Drug loading and entrapment

efficiency,

Invitro drug release Stability studies, Thermal and crystallinity

Analysis.

35,36

Floating micro sphere

Floating microspheres are in the form of powders that are free flowing. These are

composed of synthetic

polymers and proteins. Ideally Size of these floating

microspheres should be less than two hundred micro meter.

Drug is uniformly dissolved in

these microspheres. On

interaction of these micro

spheres with the fluid in the stomach, they form the

colloidal gel barrier that

controls the water intake in the microsphere and the release of drug from microspheres. Swollen polymer has air entrapped in them that gives floating property to the

microspheres, thus GRT is

increased.

DEAE cellulose,

Poly(acryl)

dextran and

Poly(acryl)

starch

Floating strength,

Floating lag time,

Total floating time,

Zeta potential,

surface charge,

Stability studies,

Invitro drug release

study

37,38

Micro porous

compartment system

In these systems the drug

pool is enclosed in a

compartment having pores all around the membrane. The trapped air in the chamber of floatation that produce

buoyancy in the gastric fluid in the stomach enters by the hole into the system then drug is dissolved into it, so in this way drug depot provides the

constant drug transport

For instant

cellulose ether

polymer, Poly

vinyl

pyrrolidine,

methylcelluloe

polymer and

Poly vinyl

alcohol and

HPMC etc.

Buoyancy test,

Drug release study,

Swelling index,

Water uptake and porosity

measurement,

Membrane

integrity and

morphology, Drug content uniformity,

In vivo gastric

retention.

39,40

Alginate beads

Floating alginate dosage forms were announced in the 1980s.

Alginates are made up of linear anionic block copolymer hetero polysaccharides that are

extracted from various species of cell walls of brown algae The formation of the hydrogel

is carried out by inotropic

gelation by reaction with the bivalent alkaline earth metals. For example:

calcium alginate form has no solubility and has resistance in acidic environment. The beads

Sodium alginate,

Low

Methoxylated

pectin,

Calcium

alginate, Ca2+

 

Particle size and

shape analysis,

Swelling index,

Floating.

Behaviour,

Mechanical

strength, Zeta

potential,

Stability studies,

Invitro drug release

studies.

27,30, 34

CONCLUSION:

Drug delivery through various gastro-retentive methods has opened a new opportunity for effective approaches to enhance patient compliance and the bioavailability of numerous medications administered orally. Numerous techniques utilizing different polymers and additional components can generate a broad array of gastro-retentive systems. The floating drug delivery method is the most widely used among gastro-retentive dosage forms. Nevertheless, significantly more research is necessary to address the numerous physiological and pharmacological challenges and to create more effective gastro-retentive dosage forms. Polymers are utilized in conventional dosage forms, such as binders for enteric-coated tablets to conceal unpleasant tastes, viscosity modifiers to regulate flow in liquids, gel formulations for semisolids, and the production of transdermal patches. Ultimately, polymers possess a vast range of uses within drug delivery systems, even though their functions have been examined. The role of polymers in delivery is continuously advancing. Polymers are often extensively utilized in the pharmaceutical sector due to their wide array of applications.

REFERENCES

  1. Cremer K. Drug delivery: Gastro-remaining dosage forms. Pharm J.1997; 259:108.
  2. Joshi P, Patel P, Modi H, Patel MR, Patel KR, Patel NM. A review on gastro retentive drug delivery system. Journal of Pharmaceutical Science and Bioscientific Research. 2012;2(3):123-8.
  3. Simons FJ, Wagner KG. Modelling, design and manufacture of innovative floating gastro retentive drug delivery systems based on hot-melt extruded tubes. European Journal of Pharmaceutics and Biopharmaceutics. 2019 Apr 1; 137:196- 208.
  4. Garg RG, Gupta GD. Progress in controlled gastro retentive delivery systems. Tropical journal of pharmaceutical research. 2008 Sep 11;7(3):1055-66.
  5. Devi, L., & Varalakshmi. (2023). Natural polymers employed in designing of Gastro retentive drug delivery systems. International Journal of Pharmaceutical Sciences Review and Research, 78(1). https://doi.org/10.47583/ijpsrr.2023.v78i01.001.
  6. Roop K Khar, SP Vyas, Farhan, JAhmad, Gaurav, K Jain, Lachman/Lieberman’s, The Theory and Practice of Industrial Pharmacy, 4: 403-448, 576-596.
  7. Shradha Tomar, Lalit Singh, Vijay Sharma, Miraculous Adjuvants: The Pharmaceutical Polymers, Int. Res. J. Pharm, 2016; 7(7).
  8. (N.d.-a). ResearchGate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/366952966_BIODEGRADABLE_POLYM ER'S_ENHANCING_DRUG_DELIVERY_ACTIVITY_IN_DIFFERENT_NOVEL_ DRUG_DELIVERY_SYSTEM.
  9. Belenkaya, E. V., Tishkov, S. V., Vinogradov, V. P., Alekseev, K. V., Markova, A. I., & Vetches, A. A. (2022). Polymeric excipients in the technology of floating drug delivery systems. Pharmaceutics, 14(12),2779. https://doi.org/10.3390/pharmaceutics 14122779.
  10. (N.d.-b). Retrieved April 25, 2025, from http://file:///C:/360ExtremeBrowserDownload/jddtadmin,+3+16-24+1928++Zubedi,+Mohammed.pdf.
  11. (N.d.). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/280858357_Designing_Polymeric_Nanopa _ Targeted Drug Delivery System.
  12.  (N.d.). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/280858357_Designing_Polymeric_Nanopa for Targeted _Drug_ Delivery_ System
  13. (N.d.-b). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/306159158_Design_of_floating_drug_delivery_systems_An_update_on_polymeric_advancements_with_special_reference_from _natural origin
  14. Anjana, M. N., Bs, V., Kumar, M., & Kumar, K. P. S. (2023). Evaluation methods and polymers used in gastro retentive dosage forms. International Journal of Biology, Pharmacy and Allied Sciences, 12(5). https://doi.org/10.31032/ijbpas/2023/12.5.7072.
  15. Akhtar, N., Thomas, S., & Songhai., A. K. (n.d.). Polymers used in floating drug delivery systems: An updated review. Jetir.org. Retrieved April 25, 2025, from https://www.jetir.org/papers/JETIR2404933.pdf.
  16. Doro?y?ski, P., Kalinowski, P., Mendyk, A., & Jachowicz, R. (2011). Gastro Retentive drug delivery systems with L-dopa based on carrageenan’s and hydroxy propyl Methylcellulose. International Journal of Pharmaceutics, 404(1–2), 169–175. https://doi.org/10.1016/j.ijpharm.2010.11.032.
  17. Iglesias, N., Galbi’s, E., Romero-Aziel, L., Benito, E., Lucas, R., García-Martín, M. G., & de-Paz, M.-V. (2020b). In-depth study into polymeric materials in low-density gastro retentive formulations. Pharmaceutics, 12(7), 636. https://doi.org/10.3390/pharmaceutics12070636.
  18. Anuria, A., Dayani, A., Murtala, F. A., Salimah, F., Akbar, N. M., & Faizan, R. A. (2023). The use of natural and synthetic polymers in the formulation of Gastro retentive drug delivery system. International Journal of Drug Delivery Technology, 13(01), 434–441. https://doi.org/10.25258/ijddt.13.1.69 .
  19.  (N.d.). Sciencedirect.com. Retrieved April 27, 2025, from https://www.sciencedirect.com/science/article/abs/pii/S0169409X0100110.
  20. (N.d.-b). Researchgate.net. Retrieved May 1, 2025, from https://www.researchgate.net/publication/271963845_TECHNIQUES_AND _POLYMERS_USED_TO_DESIGN_GASTRORETENTIVE_DRUG_DELIVERY_SYSTEMS_-_A_REVIEW.
  21. Franco, P., & De Marco, I. (2020b). The use of poly (N-vinyl pyrrolidone) in the delivery of drugs: A review. Polymers, 12(5), 1114. https://doi.org/10.3390/polym12051114.
  22. Reddy, L.H.V. and R. Murthy, Floating dosage systems in drug delivery. Critical Reviews in Therapeutic Drug Carrier System,2002; 19(6) .
  23. Nasa, P., S. Mahant, and D. Sharma, International Journal of Pharmacy and Pharmaceutical Sciences. 2010.
  24. Iann Uccelli, V., et al., Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. International journal of pharmaceutics, 1998; 174(1): 55-62.
  25. Fada, N., GASTRORETENTIVE DRUG DELIVERY SYSTEMS AS APOTENTIAL TOOL FOR ENHANCING THE EFFICACY OF ANTIBIOTICS: A REVIEW NH FODA AND SM ALI1. 2011.
  26. Moes, A., gastro retentive dosage forms. Critical reviews in therapeutic drug carrier systems, 1992; 10(2): 143-195.
  27.  Garg, R. and G. Gupta, Progress in controlled gastro retentive delivery systems. Tropical Journal of Pharmaceutical Research, 2008; 7(3): 1055-1066.
  28. Anilkumar, S., Gastro retentive drug delivery systems: An overview. Pharmacy net [Online], 2008. 6.
  29. Pawar, V.K., et al., gastro retentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug delivery, 2011; 18(2): 97-110.
  30. Nayak, A.K., J. Malakar, and K.K. Sen, gastro retentive drug delivery technologies: Current approaches and future potential. J Pharm Edu Res, 2010; 1(2): 112.
  31. Arz, R.A.K., C.S.R. Gon Gunta, and P.R. Veera Reddy, Formulation and evaluation of swellable and floating gastro retentive ciprofloxacin hydrochloride tablets. AAPS Pharm SciTech, 2009; 10(1): 220-226.
  32. Chen, R.-N., et al., Development of swelling/floating gastro retentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with< i> CYP2C9</i> polymorphism. European Journal of Pharmaceutical Sciences, 2010; 39(1): 82-89.
  33. Oth, M., et al., The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharmaceutical research, 1992; 9(3): 298-302.
  34. Whitehead, L., J.H. Collett, and J.T. Fell, Amoxycillin release from a floating dosage form based on alginates. International journal of pharmaceutics, 2000; 210(1): 45-49.
  35. Patil, C., et al., Floating microspheres: A promising approach for gastric retention. International journal of pharma research and developments, 2011; 2: 12.
  36.  Crotts, G. and T.G. Park, Preparation of porous and nonporous biodegradable polymeric hollow microspheres. Journal of Controlled Release, 1995; 35(2): 91-105.
  37. Tanwar, Y., et al., Floating microspheres: development, characterization and applications. Pharmaceutical Reviews, 2006; 4(3).
  38.  Taneja, R., et al., FLOATING MICROSPHERE: A POTENTIAL GASTRORETENTIVE DRUG DELIVERY SYSTEM. pharmacy Global, 2013; 4(4).
  39. Harrigan, R.M., Drug delivery device for preventing contact of undissolved drug with the stomach lining, 1977, Google Patents.
  40. Vyas, S. and R.K. Khar, Gastro retentive systems. Controlled drug Delivery. Vallabh Prakashan, Delhi, India, 2006: 197-217.

Reference

  1. Cremer K. Drug delivery: Gastro-remaining dosage forms. Pharm J.1997; 259:108.
  2. Joshi P, Patel P, Modi H, Patel MR, Patel KR, Patel NM. A review on gastro retentive drug delivery system. Journal of Pharmaceutical Science and Bioscientific Research. 2012;2(3):123-8.
  3. Simons FJ, Wagner KG. Modelling, design and manufacture of innovative floating gastro retentive drug delivery systems based on hot-melt extruded tubes. European Journal of Pharmaceutics and Biopharmaceutics. 2019 Apr 1; 137:196- 208.
  4. Garg RG, Gupta GD. Progress in controlled gastro retentive delivery systems. Tropical journal of pharmaceutical research. 2008 Sep 11;7(3):1055-66.
  5. Devi, L., & Varalakshmi. (2023). Natural polymers employed in designing of Gastro retentive drug delivery systems. International Journal of Pharmaceutical Sciences Review and Research, 78(1). https://doi.org/10.47583/ijpsrr.2023.v78i01.001.
  6. Roop K Khar, SP Vyas, Farhan, JAhmad, Gaurav, K Jain, Lachman/Lieberman’s, The Theory and Practice of Industrial Pharmacy, 4: 403-448, 576-596.
  7. Shradha Tomar, Lalit Singh, Vijay Sharma, Miraculous Adjuvants: The Pharmaceutical Polymers, Int. Res. J. Pharm, 2016; 7(7).
  8. (N.d.-a). ResearchGate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/366952966_BIODEGRADABLE_POLYM ER'S_ENHANCING_DRUG_DELIVERY_ACTIVITY_IN_DIFFERENT_NOVEL_ DRUG_DELIVERY_SYSTEM.
  9. Belenkaya, E. V., Tishkov, S. V., Vinogradov, V. P., Alekseev, K. V., Markova, A. I., & Vetches, A. A. (2022). Polymeric excipients in the technology of floating drug delivery systems. Pharmaceutics, 14(12),2779. https://doi.org/10.3390/pharmaceutics 14122779.
  10. (N.d.-b). Retrieved April 25, 2025, from http://file:///C:/360ExtremeBrowserDownload/jddtadmin,+3+16-24+1928++Zubedi,+Mohammed.pdf.
  11. (N.d.). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/280858357_Designing_Polymeric_Nanopa _ Targeted Drug Delivery System.
  12.  (N.d.). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/280858357_Designing_Polymeric_Nanopa for Targeted _Drug_ Delivery_ System
  13. (N.d.-b). Researchgate.net. Retrieved April 25, 2025, from https://www.researchgate.net/publication/306159158_Design_of_floating_drug_delivery_systems_An_update_on_polymeric_advancements_with_special_reference_from _natural origin
  14. Anjana, M. N., Bs, V., Kumar, M., & Kumar, K. P. S. (2023). Evaluation methods and polymers used in gastro retentive dosage forms. International Journal of Biology, Pharmacy and Allied Sciences, 12(5). https://doi.org/10.31032/ijbpas/2023/12.5.7072.
  15. Akhtar, N., Thomas, S., & Songhai., A. K. (n.d.). Polymers used in floating drug delivery systems: An updated review. Jetir.org. Retrieved April 25, 2025, from https://www.jetir.org/papers/JETIR2404933.pdf.
  16. Doro?y?ski, P., Kalinowski, P., Mendyk, A., & Jachowicz, R. (2011). Gastro Retentive drug delivery systems with L-dopa based on carrageenan’s and hydroxy propyl Methylcellulose. International Journal of Pharmaceutics, 404(1–2), 169–175. https://doi.org/10.1016/j.ijpharm.2010.11.032.
  17. Iglesias, N., Galbi’s, E., Romero-Aziel, L., Benito, E., Lucas, R., García-Martín, M. G., & de-Paz, M.-V. (2020b). In-depth study into polymeric materials in low-density gastro retentive formulations. Pharmaceutics, 12(7), 636. https://doi.org/10.3390/pharmaceutics12070636.
  18. Anuria, A., Dayani, A., Murtala, F. A., Salimah, F., Akbar, N. M., & Faizan, R. A. (2023). The use of natural and synthetic polymers in the formulation of Gastro retentive drug delivery system. International Journal of Drug Delivery Technology, 13(01), 434–441. https://doi.org/10.25258/ijddt.13.1.69 .
  19.  (N.d.). Sciencedirect.com. Retrieved April 27, 2025, from https://www.sciencedirect.com/science/article/abs/pii/S0169409X0100110.
  20. (N.d.-b). Researchgate.net. Retrieved May 1, 2025, from https://www.researchgate.net/publication/271963845_TECHNIQUES_AND _POLYMERS_USED_TO_DESIGN_GASTRORETENTIVE_DRUG_DELIVERY_SYSTEMS_-_A_REVIEW.
  21. Franco, P., & De Marco, I. (2020b). The use of poly (N-vinyl pyrrolidone) in the delivery of drugs: A review. Polymers, 12(5), 1114. https://doi.org/10.3390/polym12051114.
  22. Reddy, L.H.V. and R. Murthy, Floating dosage systems in drug delivery. Critical Reviews in Therapeutic Drug Carrier System,2002; 19(6) .
  23. Nasa, P., S. Mahant, and D. Sharma, International Journal of Pharmacy and Pharmaceutical Sciences. 2010.
  24. Iann Uccelli, V., et al., Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. International journal of pharmaceutics, 1998; 174(1): 55-62.
  25. Fada, N., GASTRORETENTIVE DRUG DELIVERY SYSTEMS AS APOTENTIAL TOOL FOR ENHANCING THE EFFICACY OF ANTIBIOTICS: A REVIEW NH FODA AND SM ALI1. 2011.
  26. Moes, A., gastro retentive dosage forms. Critical reviews in therapeutic drug carrier systems, 1992; 10(2): 143-195.
  27.  Garg, R. and G. Gupta, Progress in controlled gastro retentive delivery systems. Tropical Journal of Pharmaceutical Research, 2008; 7(3): 1055-1066.
  28. Anilkumar, S., Gastro retentive drug delivery systems: An overview. Pharmacy net [Online], 2008. 6.
  29. Pawar, V.K., et al., gastro retentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug delivery, 2011; 18(2): 97-110.
  30. Nayak, A.K., J. Malakar, and K.K. Sen, gastro retentive drug delivery technologies: Current approaches and future potential. J Pharm Edu Res, 2010; 1(2): 112.
  31. Arz, R.A.K., C.S.R. Gon Gunta, and P.R. Veera Reddy, Formulation and evaluation of swellable and floating gastro retentive ciprofloxacin hydrochloride tablets. AAPS Pharm SciTech, 2009; 10(1): 220-226.
  32. Chen, R.-N., et al., Development of swelling/floating gastro retentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose for Losartan and its clinical relevance in healthy volunteers with< i> CYP2C9</i> polymorphism. European Journal of Pharmaceutical Sciences, 2010; 39(1): 82-89.
  33. Oth, M., et al., The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharmaceutical research, 1992; 9(3): 298-302.
  34. Whitehead, L., J.H. Collett, and J.T. Fell, Amoxycillin release from a floating dosage form based on alginates. International journal of pharmaceutics, 2000; 210(1): 45-49.
  35. Patil, C., et al., Floating microspheres: A promising approach for gastric retention. International journal of pharma research and developments, 2011; 2: 12.
  36.  Crotts, G. and T.G. Park, Preparation of porous and nonporous biodegradable polymeric hollow microspheres. Journal of Controlled Release, 1995; 35(2): 91-105.
  37. Tanwar, Y., et al., Floating microspheres: development, characterization and applications. Pharmaceutical Reviews, 2006; 4(3).
  38.  Taneja, R., et al., FLOATING MICROSPHERE: A POTENTIAL GASTRORETENTIVE DRUG DELIVERY SYSTEM. pharmacy Global, 2013; 4(4).
  39. Harrigan, R.M., Drug delivery device for preventing contact of undissolved drug with the stomach lining, 1977, Google Patents.
  40. Vyas, S. and R.K. Khar, Gastro retentive systems. Controlled drug Delivery. Vallabh Prakashan, Delhi, India, 2006: 197-217.

Photo
Naga Jyotsna Bandi
Corresponding author

Malla Reddy Pharmacy College, Secunderabad, Maisammaguda, Dhulapally, Medchal-Malkajgiri

Photo
T. Kouserbanu
Co-author

Malla Reddy Pharmacy College, Secunderabad, Maisammaguda, Dhulapally, Medchal-Malkajgiri

Photo
V. Priya Darshini
Co-author

Malla Reddy Pharmacy College, Secunderabad, Maisammaguda, Dhulapally, Medchal-Malkajgiri

Photo
V. Pravallika
Co-author

Malla Reddy Pharmacy College, Secunderabad, Maisammaguda, Dhulapally, Medchal-Malkajgiri

Photo
G.Tulja Rani
Co-author

Malla Reddy Pharmacy College, Secunderabad, Maisammaguda, Dhulapally, Medchal-Malkajgiri

Naga Jyotsna Bandi, T. Kouserbanu, V. Priya Darshini, V. Pravallika, G. Tulja Rani, Polymers And Techniques Used in The Development of Gastro Retentive Drug Delivery System, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 4215-4225. https://doi.org/10.5281/zenodo.15736216

More related articles
Use of Potato and Curry Leaves for Anti-Ageing Cre...
Aayushi Yelgurwar , Chhavi Rahangdale , Divyani Dahake, Harshada ...
Varenicline Tartrate: A New Hope for Those Seeking...
Raj Chauhan, Khushbu Patel, Dr. Khushbu Patel, Dr. C. N. Patel, S...
Studies on evaluation of Lipid Profile and Cardiac...
DR.RAJA KUMAR PARABATHINA, Dilnawaz Ansari, Kishor Deshmukh, Yash...
Formulation And Evaluation Of Fast Dissolving Sodium Diclofenac Sodium Tablet...
Sujit S. Shinde , Sachitanand B. biradar , Avinash A Bhagat , Madan K. Shinde , ...
Exploring Corticosterone-Induced Depression Models: Mechanisms, Therapeutic Inte...
Meghashri Mastoli, Snehal Sonar, Ashiya Choudhary , Rutuja Khilare, Vivek Kumbhar , Dr. P. L. Ladda,...
The Role of Artificial Intelligence in Revolutionizing Infertility Diagnosis and...
Amruta Rajput , Shivprasad Deokar , Dr. Kawade Rajendra, ...
Related Articles
The Integration of Traditional and Modern Medicine: Future Prospects for Pharmac...
Manojit Kundu, Shaheen Parveen, Meghna Chowdhury, Rishikesh Ishore, Atanu Bag, Souvik Bhattacharyya,...
Cancer And Food Consumption...
Ahirrao Sangita, Shirsath Priya, Wankhede Neha, Suryawanshi Shraddha, Mairal Pooja, TufailDana, Nika...
A Review on Formulation and Evaluation of BI- Layered Tablet of Divalproex Sodiu...
Salve Bhumika, Zanjad Aniket, Kalamkar Tejas, Deshmukh Komal, ...
Use of Potato and Curry Leaves for Anti-Ageing Cream ...
Aayushi Yelgurwar , Chhavi Rahangdale , Divyani Dahake, Harshada Borekar, Mitali Bodhankar , ...
More related articles
Use of Potato and Curry Leaves for Anti-Ageing Cream ...
Aayushi Yelgurwar , Chhavi Rahangdale , Divyani Dahake, Harshada Borekar, Mitali Bodhankar , ...
Varenicline Tartrate: A New Hope for Those Seeking to Quit Smoking ...
Raj Chauhan, Khushbu Patel, Dr. Khushbu Patel, Dr. C. N. Patel, Sweety Oza, ...
Studies on evaluation of Lipid Profile and Cardiac Biomarkers of Hospital Popula...
DR.RAJA KUMAR PARABATHINA, Dilnawaz Ansari, Kishor Deshmukh, Yashashri Alamwar, ...
Use of Potato and Curry Leaves for Anti-Ageing Cream ...
Aayushi Yelgurwar , Chhavi Rahangdale , Divyani Dahake, Harshada Borekar, Mitali Bodhankar , ...
Varenicline Tartrate: A New Hope for Those Seeking to Quit Smoking ...
Raj Chauhan, Khushbu Patel, Dr. Khushbu Patel, Dr. C. N. Patel, Sweety Oza, ...
Studies on evaluation of Lipid Profile and Cardiac Biomarkers of Hospital Popula...
DR.RAJA KUMAR PARABATHINA, Dilnawaz Ansari, Kishor Deshmukh, Yashashri Alamwar, ...